Adding Urea to the Final Dialysis Fluid
Part of paid clinical trials in San Francisco, California.
- Sponsor
- University of California, San Francisco
- Study ID
- NCT06366230
- Phase
- PHASE1/PHASE2
- Status
- Recruiting
Conditions
- Dysequilibrium Syndrome
- ESRD
- Hyperkalemia
- Metabolic Acidosis
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Urea in the dialysate — DRUGAdding urea to the dialysis fluid. Ure-Na 15 grams would be used. It would be added to the acid component of the dialysis fluid. The amount added would depend on the serum BUN concentration and is determined by a simple calculation. It would be available in powder form. Urea would be added just to the first 1-3 dialysis treatments as needed.
Study Details
At times patients with advanced renal failure present with severe hyperkalemia or acidosis and very high serum blood urea nitrogen (BUN) concentrations. These patients cannot be dialyzed aggressively as the lowering of serum BUN may results in disequilibrium syndrome but on the other hand they need aggressive dialysis in order to lower their serum potassium or fix their severe acidosis. If one is able to add urea to the dialysis fluid, one can prevent the rapid lowering of serum BUN and osmolality at the same time as doing aggressive dialysis to lower serum potassium and/or fix the metabolic acidosis.
Key Dates
- Start date
- Sep 16, 2025
- Status verified
- Feb 2026
- Primary completion
- Jun 30, 2028
- Completion
- Jun 30, 2028
Study Design
- Enrollment
- 20 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: Urea dialysatePatients who had urea added to the final dialysis fluid
Primary Outcome Measure
Disequilibrium [ Time Frame: within 24 hours after starting dialysis ]
Central Contacts
- Ramin Sam, MD6282066605
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Zuckerberg San Francisco General Hospital | San Francisco | California | 94110 |
Find similar trials in San Francisco, CA
By research site
Related Studies
- Sodium Bicarbonate and Mitochondrial Energetics in Persons With CKDPHASE2 · Recruiting · University of California, Davis · Sacramento, California
- SAVE-FistulaS: the SelfWrap-Assisted ArterioVEnous Fistulas StudyRecruiting · VenoStent · Bullhead City, Arizona
- Repletion of Ergothioneine in Patients With Kidney FailureRecruiting · Stanford University · Palo Alto, California
- A Study to Evaluate the Efficacy and Safety of Veverimer for the Treatment of Metabolic AcidosisPHASE3 · Recruiting · Renibus Therapeutics, Inc. · Chula Vista, California